market waiting on execution obviously, needs to see evidence of covid cases also falling/deaths falling. COVID cases are a big concern for any company that isnt benefiting. SP has been more of less fairly ordinary, well below IPO now.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%